CardioFocus

Marlborough, United States Founded: 1990 • Age: 36 yrs
Endoscopic catheter for atrial fibrillation ablation is developed.

About CardioFocus

CardioFocus is a Healthcare company based in Marlborough (United States) founded in 1990. Endoscopic catheter for atrial fibrillation ablation is developed. CardioFocus has raised $260.86 million across 22 funding rounds from investors including Boston Scientific, SVB and HHS. CardioFocus offers products and services including HeartLight X3 and Centauri System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is CardioFocus Inc. Its competitors include AtaCor Medical, AtriCure and Kestra Medical Technologies; 2 of its 3 listed competitors have raised funding.

Company details

CardioFocus was founded in 1990 and is headquartered in Marlborough, United States. The company operates in the medical device sector, specializing in cardiology solutions for atrial fibrillation treatment. The HeartLight Endoscopic Ablation System is utilized to enable visual guidance of laser energy for pulmonary vein isolation during procedures. Products are distributed across Europe and Australia, with FDA approval obtained for the United States market.

  • Headquarters Marlborough, United States
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website cardiofocus.com
  • Social LinkedIn X YouTube
  • Legal Name Cardiofocus Inc.
Key Metrics
  • Total Equity Funding
    $260.86M (USD)

    in 22 rounds

  • Latest Funding Round
    $31.76M (USD), Series E

    Feb 2023

  • Investors

Products & Services of CardioFocus

CardioFocus offers a comprehensive portfolio of products and services, including HeartLight X3 and Centauri System.

HeartLight X3
Laser Ablation System

Provides precise laser technology for atrial fibrillation ablation procedures.

Centauri System
Pulsed Field Ablation

Delivers efficient PFA technology for cardiac arrhythmia management.

Apps and channels of CardioFocus

its YouTube channel CardioFocus, Inc. has 283 subscribers and 18 videos.

CardioFocus, Inc.
YouTube 283 subscribers 18 videos Music
Open channel

Videos from CardioFocus

The most watched videos on CardioFocus's YouTube channel, CardioFocus, Inc. (283 subscribers). Click a video to play it here.

Atrial Fibrillation Animation | HeartLight X3 Animation
6.5K views
Atrial Fibrillation Animation | HeartLight Animation
6.4K views
HeartLight X3 Cardiac Ablation Procedure Video | Jessa Hospital | Hasselt, Belgium
2.4K views
HeartLight X3 Cardiac Ablation Procedure Video | OLV Aalst Hospital | Aalst, Belgium
2.2K views

More on CardioFocus, Inc..

Funding Insights of CardioFocus

CardioFocus has successfully raised a total of $260.86M across 22 strategic funding rounds. The most recent funding activity was a Series E round of $31.76 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $260.86M
  • Total Rounds 22
  • Last Round Series E — $31.76M
  • First Round $9.6M

    (Jan 2000)

  • Investors Count 18

Latest 10 of 22 funding rounds of CardioFocus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2023Debt – Conventional––
–
Feb 2023$31.76MSeries E––
–
Apr 2022$4MSeries E––
–
May 2019Debt – Conventional––
May 2019$55MSeries E––
–
Jun 2018$21MDebt – Conventional––
Apr 2018$13MSeries E––
–
Mar 2017$20MSeries E––
–
Mar 2017$20.18MSeries E––
–
May 2016$8MSeries E––
–
Valuation history

18 investors in total: 18 institutional.

Investors in CardioFocus

CardioFocus has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, SVB and HHS.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
gpb-cap.com
Early stage VC firm investing in the US and Korea
oxbio.comBoston, United States
aurorafunds.com
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
amvpartners.comDuluth, United States
kestrelinvestments.com
Venture capital fund focused on early-stage healthcare startups
svhealthinvestors.comBoston, United States
Venture debt firm focused on the life sciences sector
2002oxfordfinance.comAlexandria, United States
First Alliance is engaged in wealth management and investment services.
1997firstalliance.chZurich, Switzerland
Limited information is provided about KBL Healthcare Ventures.
kblhealthcare.com
Diversified investment management services are offered across asset classes.
2017klimllc.comNew York, United States
Premium access

Investor details for CardioFocus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CardioFocus

20 people are tracked at CardioFocus (6 in leadership, 6 in board & advisors, 8 in team).

NameRoleGroup
Jerry Melsky
VP, EngineeringLeadership
Steve Ogilvie
CFOLeadership
Scott Fletcher
VP, Finance & AdministrationLeadership
Mark Casey
VP, OperationsLeadership
Ian Christianson
Vp, Regulatory, Quality, And Clinical AffairsLeadership
Lisa Hausmann
Senior Director, Clinical AffairsLeadership
Paul Laviolette
ChairmanBoard & advisors
Omar Amirana
DirectorBoard & advisors
Charles Larsen
DirectorBoard & advisors
Bruce Robertson
DirectorBoard & advisors
Gwen Watanabe
DirectorBoard & advisors
Patrick Wethington
DirectorBoard & advisors
Christopher C.
Assistant ControllerTeam
Chris Brushett
Principal Catheter EngineerTeam
Caleb Tshaba
Catheter Manufacturing EngineerTeam
Danielle Peart, CPA
ControllerTeam
Hamid Massoud
Principal R&d EngineerTeam
Daniel Lee
Sr. Manufacturing EngineerTeam
Curtis Keohane
Senior Product Design EngineerTeam
Pete Bell
SVP Global Business DevelopmentTeam
Premium access

Complete people profiles for CardioFocus

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CardioFocus

3 dated milestones of CardioFocus across 33 years, from founding to its latest funding, stage changes and deals.

  1. Founded CardioFocus is founded.
  2. Funding First funding round of $9.6M.
  3. Funding Latest funding round, Series E, of $31.8M.

Competitors of CardioFocus

CardioFocus has 3 listed competitors in our database, 2 of them funded. They include AtaCor Medical, AtriCure and Kestra Medical Technologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
atacor.com2014San Clemente, United States$136.8M15
An implantable pacemaker system is developed for cardiac pacing therapy.
atricure.com2000Mason, United States1,874
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
kestramedical.com2014Kirkland, United States$196M118
Medical devices are developed to support cardiovascular patients at risk.
Premium access

Detailed competitors of CardioFocus

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CardioFocus

The website of CardioFocus (cardiofocus.com) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▲ 49.8% vs previous month

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as CardioFocus (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cardiofocus

Premium access

Complete news archive for CardioFocus

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CardioFocus

CardioFocus was founded in 1990 and raised its 1st funding round 10 years after it was founded.

CardioFocus is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.

CardioFocus is a funded company, having raised a total of $260.86M across 22 funding rounds to date. The company's 1st funding round was a Series E of $8M, raised on Jan 2000.

CardioFocus was founded in 1990 and is headquartered in Marlborough, United States. The company operates in the medical device sector, specializing in cardiology solutions for atrial fibrillation treatment. The HeartLight Endoscopic Ablation System is utilized to enable visual guidance of laser energy for pulmonary vein isolation during procedures. Products are distributed across Europe and Australia, with FDA approval obtained for the United States market.

CardioFocus's top competitors include AtaCor Medical, AtriCure and Kestra Medical Technologies.

CardioFocus offers HeartLight X3 and Centauri System.

CardioFocus has 18 investors. Key investors include Boston Scientific, SVB, HHS, Boston University, and Oxford Finance.

CardioFocus operates through Cardiofocus Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available